Rigid Endoscopes Market Poised to Reach $11.52B by 2033 on Minimally Invasive Demand

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Rigid endoscopes market to grow from $7.36B to $11.52B by 2033, driven by minimally invasive surgery demand and technological advances in imaging capabilities.

Rigid Endoscopes Market Poised to Reach $11.52B by 2033 on Minimally Invasive Demand

The global rigid endoscopes market is expected to expand significantly over the next eight years, growing from $7.36 billion in 2025 to $11.52 billion by 2033, according to market analysis. This represents a compound annual growth rate of 5.84%, driven by the ongoing shift toward minimally invasive surgical procedures across multiple medical specialties and the proliferation of ambulatory surgery centers worldwide.

Technological innovation serves as a key catalyst for market expansion, with advances in high-definition and 4K imaging capabilities enhancing surgical precision and clinical outcomes. These improvements are enabling surgeons to perform complex procedures with reduced patient trauma, shorter recovery times, and improved safety profiles, thereby accelerating adoption rates across healthcare systems globally.

Geographically, North America maintains a dominant position with 41% of the current market share, reflecting the region's established healthcare infrastructure and high surgical volumes. Asia-Pacific is positioned as the fastest-growing region, projected to achieve an 8.00% compound annual growth rate through the forecast period, driven by expanding healthcare investment, rising surgical demand, and increasing modernization of medical facilities across developing economies.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 19

Related Coverage

GlobeNewswire Inc.

Boston Scientific Faces Securities Fraud Lawsuit Over Overstated EP Growth Claims

Boston Scientific faces class action lawsuit alleging material misstatements about electrophysiology growth. Stock fell 17.6% after disclosing slower market growth and competitive pressures.

BSX
GlobeNewswire Inc.

Stryker Schedules 2026 Annual Meeting, Raises Quarterly Dividend to $0.88

Stryker schedules virtual annual shareholder meeting for May 6, 2026, declares $0.88 quarterly dividend payable April 30, 2026.

SYK
GlobeNewswire Inc.

Boston Scientific Faces Securities Lawsuit Over Electrophysiology Segment Misstatements

Boston Scientific faces class action over false electrophysiology segment statements. Investors from July 2025–February 2026 may recover damages; lead plaintiff deadline May 4, 2026.

BSX
The Motley Fool

Boone Capital Exits 372% Biotech Winner to Chase Emerging Clinical Plays

Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.

MDTTYRAIONS
GlobeNewswire Inc.

Law Firm Launches Securities Fraud Investigations Into Four Public Companies

Law firm investigates securities fraud claims against ASP Isotopes, Integer Holdings, Molina Healthcare, and Soleno Therapeutics for alleged misstatements regarding technology, competitive position, medical costs, and drug safety.

ASPIITGRMOH
The Motley Fool

Tenon Medical Doubles Q4 Revenue on FDA Clearance, Eyes Aggressive 2026 Expansion

Tenon Medical reports 92% Q4 revenue growth to $1.5M, achieves 69% gross margins, secures FDA clearance and $4.3M financing for spine fusion device expansion.

TNONTNONW